NCT02782676View on ClinicalTrials.gov

Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD)

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

June 21, 2016

Primary Completion Date

May 4, 2017

Study Completion Date

May 4, 2017

Conditions
Cataract
Interventions
DEVICE

Investigational Healon5 OVD

ophthalmic viscosurgical device

DEVICE

Healon5 OVD

ophthalmic viscosurgical device

All Listed Sponsors
lead

Abbott Medical Optics

INDUSTRY

NCT02782676 - Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD) | Biotech Hunter | Biotech Hunter